Sophia T. Pallenberg

Effects of Elexacaftor/Tezacaftor/Ivacaftor Therapy on Lung Clearance Index and Magnetic Resonance Imaging in Patients with Cystic Fibrosis and One or Two <i>F508del</i> Alleles

Simon Y. Graeber, Diane M. Renz, Mirjam Stahl et al. · American Journal of Respiratory and Critical Care Medicine · 2022 · 113 citations

Impact of Elexacaftor/Tezacaftor/Ivacaftor Therapy on the Cystic Fibrosis Airway Microbial Metagenome

Sophia T. Pallenberg, Marie‐Madlen Pust, Ilona Rosenboom et al. · Microbiology Spectrum · 2022 · 46 citations · Full text

PREFUL MRI for Monitoring Perfusion and Ventilation Changes after Elexacaftor-Tezacaftor-Ivacaftor Therapy for Cystic Fibrosis: A Feasibility Study

Martha Dohna, Andreas Voskrebenzev, Filip Klimeš et al. · Radiology Cardiothoracic Imaging · 2024 · 32 citations · Full text

Impact of elexacaftor/tezacaftor/ivacaftor therapy on lung clearance index and magnetic resonance imaging in children with cystic fibrosis and one or two<i>F508del</i>alleles

Mirjam Stahl, Martha Dohna, Simon Y. Graeber et al. · European Respiratory Journal · 2024 · 32 citations · Full text

CFTR modulation with elexacaftor-tezacaftor-ivacaftor in people with cystic fibrosis assessed by the β-adrenergic sweat rate assay

Sophia T. Pallenberg, Sibylle Junge, Felix C. Ringshausen et al. · Journal of Cystic Fibrosis · 2021 · 17 citations · Full text